about
Inhaled nitric oxide for respiratory failure in preterm infantsInhaled nitric oxide for respiratory failure in preterm infantsNitric oxide for respiratory failure in infants born at or near termThe OHRP and SUPPORTInternational survey on diagnosis and management of hypotension in extremely preterm babies.Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.Review: probiotics prevented necrotising enterocolitis and reduced mortality in preterm neonates.Common hemodynamic problems in the neonate.Management during the first 72 h of age of the periviable infant: an evidence-based review.End-of-life decisions for extremely low-gestational-age infants: why simple rules for complicated decisions should be avoided.Communication with parents concerning withholding or withdrawing of life-sustaining interventions in neonatology.Co-bedding between preterm twins attenuates stress response after heel lance: results of a randomized trial.Trying to predict the future of ex-preterm infants: who benefits from a brain MRI at term?Changes in perinatal hospital deaths occurring outside the neonatal intensive care unit over a decade.The changing epidemiology of preterm twins and triplets admitted to neonatal intensive care units in Canada, 2003 to 2008.New reference curves for head circumference at birth, by gestational age.Personalized medicine in the NICU.Cohort study of probiotics in a North American neonatal intensive care unit.The politics of probiotics: probiotics, necrotizing enterocolitis and the ethics of neonatal research.Preventing postnatal growth restriction in infants with birthweight less than 1300 g.Norepinephrine infusion improves haemodynamics in the preterm infants during septic shock.Number needed to suffer?What is an "appropriate code"?Cobedding and Recovery Time After Heel Lance in Preterm Twins: Results of a Randomized TrialPulse oximetry is a cost-effective addition in screening newborns for congenital heart defects
P50
Q24235781-08A1639F-C6D4-46C5-A1CA-A261E46EB1A3Q24243892-A3CF2918-5F7A-4D59-A4BD-68B841178C4CQ24244303-C9491EC1-475C-4D9D-AFFA-97476361EE2AQ28292121-966CA6AA-D9E5-47A8-A90E-DC6F84713AFDQ33656767-178337B3-25C7-4094-AB96-0955BCFDF850Q34247861-4AC93A28-CBA2-46B2-9049-4380AF5C3149Q37886460-8EFB3264-5ECD-4F3C-84AE-AB3CC1DCBAE9Q38111937-3C90D7D2-FAC0-4606-8AA7-8CB51B21FB10Q38182278-7DDDBA0A-D87E-4793-88C3-A766D41B47F6Q38182280-93674E7D-47D2-4BC1-9E17-362A0F3B9707Q38182281-594504D1-04A6-4440-B125-EE3187F6CA6EQ38440201-9CE0D5DA-6E42-456A-ABE2-AB6255E0415DQ39584771-1E04B563-9AF0-4F4A-8902-AE968113C7A9Q40231362-5E7095D6-943F-425A-BD3B-FF5A37282DCFQ43874947-7C045608-FD5E-4BAE-BA71-1A664E007842Q44099374-DF445B83-1B43-4E16-8CAA-971A6F163693Q44207872-256CE627-F974-4D78-A997-B7852BE46D78Q44880218-3925C584-4098-43CF-9104-86249E1FAADAQ46475461-433B4AD4-367C-4CF1-A029-B26556C06E23Q48045005-24632502-8044-4C53-8E1C-59E891CB768BQ48220760-C2B4EF3F-DBD8-499E-97C4-FA64845A5751Q48305054-7F574479-ED85-4E42-A61C-F2961DD80203Q56776095-9A80CC38-C421-4738-80E3-15CE727BA49CQ60511619-7B6B51BF-63C7-4120-B76C-EBFDD6ABCB2DQ84859140-593421EE-8120-4508-8951-CABFC9636EDF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Keith J Barrington
@ast
Keith J Barrington
@en
Keith J Barrington
@es
Keith J Barrington
@nl
type
label
Keith J Barrington
@ast
Keith J Barrington
@en
Keith J Barrington
@es
Keith J Barrington
@nl
prefLabel
Keith J Barrington
@ast
Keith J Barrington
@en
Keith J Barrington
@es
Keith J Barrington
@nl
P106
P1153
7005073044
P31
P496
0000-0001-9669-5094